FDA decree limits Genzyme drug distribution; WHO scolds EU for customs games delaying Indian drugs;

> Via consent decree, the FDA is restricting Genzyme's U.S. distribution of thyroid cancer drug Thyrogen. FDA Statement

> WHO calls EU on counterfeit/patent gamesmanship in slowing drug shipments from India. Article

> Canadian ointment and creams maker Contract Pharmaceuticals is closing its Buffalo, NY, facility by the end of 2011, eliminating 260 jobs. Article

> Inefficiency and lack of coordination between India's drug-purchasing and drug-manufacturing agencies has led to their merger by Health Minister Maithripala Sirisena. Article

> The Abbott Labs acquisition of India's Piramal Healthcare Solutions will drive more cross-border M&A activity, says ARC Advisory. Post